Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / RCEL - AVITA Medical: Financial Challenges Ahead Despite Innovative RECELL Device


RCEL - AVITA Medical: Financial Challenges Ahead Despite Innovative RECELL Device

2024-05-21 17:33:23 ET

Summary

  • AVITA Medical specializes in regenerative medicine and has an innovative device for skin restoration that treats full-thickness skin defects and vitiligo.
  • The RECELL device uses a patient's skin cells to create a spray-on suspension for healing and repigmentation. This procedure requires less donor skin and leads to faster wound recovery.
  • RCEL's seemingly cheap P/S ratio is likely due to its operational inefficiency, which I don’t think will improve in the near term.
  • Despite its innovative technology, I deem RCEL a "hold" due to financial concerns. Management needs to focus on achieving profitability to avoid dilution.

...

For further details see:

AVITA Medical: Financial Challenges Ahead, Despite Innovative RECELL Device
Stock Information

Company Name: Avita Medical Inc.
Stock Symbol: RCEL
Market: NYSE
Website: avitamedical.com

Menu

RCEL RCEL Quote RCEL Short RCEL News RCEL Articles RCEL Message Board
Get RCEL Alerts

News, Short Squeeze, Breakout and More Instantly...